ATE20182T1 - Verfahren zur herstellung von tabletten. - Google Patents

Verfahren zur herstellung von tabletten.

Info

Publication number
ATE20182T1
ATE20182T1 AT80300008T AT80300008T ATE20182T1 AT E20182 T1 ATE20182 T1 AT E20182T1 AT 80300008 T AT80300008 T AT 80300008T AT 80300008 T AT80300008 T AT 80300008T AT E20182 T1 ATE20182 T1 AT E20182T1
Authority
AT
Austria
Prior art keywords
tablets
production
Prior art date
Application number
AT80300008T
Other languages
English (en)
Inventor
Gunnar Aslak Sothmann
Esko Veikko Marttila
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE20182T1 publication Critical patent/ATE20182T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT80300008T 1979-02-02 1980-01-02 Verfahren zur herstellung von tabletten. ATE20182T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI790350A FI63335B (fi) 1979-02-02 1979-02-02 Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
EP80300008A EP0014514B1 (de) 1979-02-02 1980-01-02 Verfahren zur Herstellung von Tabletten

Publications (1)

Publication Number Publication Date
ATE20182T1 true ATE20182T1 (de) 1986-06-15

Family

ID=8512353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80300008T ATE20182T1 (de) 1979-02-02 1980-01-02 Verfahren zur herstellung von tabletten.

Country Status (15)

Country Link
US (1) US4351825A (de)
EP (1) EP0014514B1 (de)
JP (1) JPS55129222A (de)
AR (1) AR222207A1 (de)
AT (1) ATE20182T1 (de)
CA (1) CA1144071A (de)
DE (1) DE3071625D1 (de)
DK (1) DK28480A (de)
ES (1) ES8102702A1 (de)
FI (1) FI63335B (de)
GR (1) GR65623B (de)
IE (1) IE51741B1 (de)
NO (1) NO149490B (de)
PT (1) PT70719A (de)
ZA (1) ZA80553B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
US4844984A (en) * 1984-03-19 1989-07-04 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US4624945A (en) * 1984-03-19 1986-11-25 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US5000957A (en) * 1984-03-19 1991-03-19 Alza Corporation Dispenser comprising hydrophilic osmopolymer
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
US4729793A (en) * 1985-08-09 1988-03-08 Alza Corporation Composition for manufacturing wall of dispensing device
US4927633A (en) * 1984-03-19 1990-05-22 Alza Corporation Dispenser for delivering drug to livestock
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
IT1204294B (it) * 1986-03-11 1989-03-01 Gentili Ist Spa Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
WO1989009066A1 (en) * 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
US6056992A (en) * 1988-06-02 2000-05-02 Campbell Soup Company Encapsulated additives
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
IL96311A (en) † 1989-12-01 1995-05-26 Abbott Lab Medications with delayed release
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US5431630A (en) * 1993-09-07 1995-07-11 Surgic-Acid, Inc. Needle guard and nonreusable syringe
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
CA2154640A1 (en) * 1994-07-27 1996-01-28 Fakhruddin Ahmed Coated pesticidal agents, processes for their preparation and compositions containing them
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6776996B2 (en) 1997-07-09 2004-08-17 Basf Aktiengesellschaft Pesticidal matrices
ID20839A (id) * 1997-07-09 1999-03-11 American Cyanamid Co Bahan acuan pestisida berlapis lebih baik, pengolahan pada pembuatannya serta komposisi-komposisi yang terkandung di dalamnya
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
KR100620935B1 (ko) 1998-03-19 2006-09-13 브리스톨-마이어스스퀴브컴파니 용해도가 높은 약물에 대한 2상 서방성 전달 시스템과 방법
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
AU779277B2 (en) * 1999-06-04 2005-01-13 Alza Corporation Implantable gel compositions and method of manufacture
EP1949890A3 (de) 1999-06-04 2011-05-18 ALZA Corporation Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
US6676966B1 (en) 2000-05-09 2004-01-13 Intellipharmaceutics Corp. Extended release metformin hydrochloride formulations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
DE10127134A1 (de) * 2001-06-05 2002-12-12 Roehm Gmbh verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
US7214387B2 (en) * 2002-08-02 2007-05-08 Penwest Pharmaceuticals Company Sustained release formulations of metformin
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PE20060003A1 (es) 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
WO2018107080A1 (en) 2016-12-08 2018-06-14 R.P. Scherer Technologies, Llc A method to relieve stress in capsule shells to reduce propensity to break

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
SE353229B (de) * 1970-06-04 1973-01-29 Haessle Ab
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS6191314A (ja) * 1984-10-12 1986-05-09 Nippon Kokan Kk <Nkk> 取鍋精錬炉による溶鋼の精錬方法

Also Published As

Publication number Publication date
EP0014514B1 (de) 1986-06-04
PT70719A (en) 1980-02-01
ES488168A0 (es) 1981-02-16
EP0014514A2 (de) 1980-08-20
FI63335B (fi) 1983-02-28
DK28480A (da) 1980-08-03
EP0014514A3 (en) 1981-06-10
AR222207A1 (es) 1981-04-30
ZA80553B (en) 1981-02-25
US4351825A (en) 1982-09-28
GR65623B (en) 1980-10-15
CA1144071A (en) 1983-04-05
IE800202L (en) 1980-08-02
ES8102702A1 (es) 1981-02-16
IE51741B1 (en) 1987-03-18
JPS55129222A (en) 1980-10-06
NO794290L (no) 1980-08-05
FI790350A7 (fi) 1980-08-03
DE3071625D1 (en) 1986-07-10
NO149490B (no) 1984-01-23

Similar Documents

Publication Publication Date Title
ATE20182T1 (de) Verfahren zur herstellung von tabletten.
AT373146B (de) Verfahren zur herstellung von tabletten
LU79363A1 (de) Verfahren zur herstellung von diazepinderivaten
ATE5874T1 (de) Verfahren zur herstellung von platinkomplexen.
ATE29500T1 (de) Verfahren zur herstellung von nphosphonomethylglycin.
AT354422B (de) Verfahren zur herstellung von m-halogenmethyl- diphenylaethern
AT349454B (de) Verfahren zur herstellung von alfa-cyano- benzylestern
LU78484A1 (de) Verfahren zur herstellung von benzoxazolyl-phenyl-stilbenen
DD135823A5 (de) Verfahren zur herstellung von monochlorpinakolin
ATE13421T1 (de) Verfahren zur herstellung von 4-aminobutters|ureamide.
ATA980876A (de) Verfahren zur herstellung von 2-oxo-pyrrolidin- n-alkylamiden
DD137709A5 (de) Verfahren zur herstellung von thiophenolen
DD148954A1 (de) Verfahren zur herstellung von halogenierungsmitteln
AT348506B (de) Verfahren zur herstellung von bis- polybromphenoxy-alkanen
AT347918B (de) Verfahren zur herstellung von hexachlor- cyclobuten
DD161153A3 (de) Verfahren zur herstellung von glucoseisomerase
ATA625377A (de) Verfahren zur herstellung von delta-l- glutamyltaurin
DD130945A1 (de) Verfahren zur herstellung von rasierseife
DD131932A1 (de) Verfahren zur herstellung von eisenphthalocyanin
ATE4798T1 (de) Verfahren zur herstellung von hexahydronaphthacen-derivaten.
DD134518A1 (de) Verfahren zur herstellung von methylaminen
ATE1527T1 (de) Verfahren zur herstellung von tetramisol.
ATA814978A (de) Verfahren zur herstellung von 2,6-methano-3- -benzazocinen
AT346299B (de) Verfahren zur herstellung von 6-acyloxy-4- methyl-hexa-2,4-dien-1-al
ATE28879T1 (de) Verfahren zur herstellung von polyolefin.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time